Activity Chair:
Peter P. Toth, MD, PhD
Director of Preventative Cardiology
CGH Medical Center
Sterling, IL
Professor of Clinical Family and Community Medicine
University of Illinois College of Medicine
Peoria, IL
Professor of Clinical Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, MI
Adjunct Associate Professor Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Planning Committee and Faculty:
Sergio Fazio, MD, PhD
William and Sonja Connor Professor of Preventive Cardiology
Professor of Medicine
Director, Center of Preventive Cardiology
Oregon Health & Science University
Portland, OR
Allan D. Sniderman, MD
Director
Mike Rosenbloom Laboratory for Cardiovascular Research
Royal Victoria Hospital
Montreal, QC
Reviewers:
Michael Miller, MD
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 1/11/2018)
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
Planning Committee and faculty report the following relationship(s) which are accurate at the time of original content release (February 24, 2016):
Peter P. Toth, MD, PhD
Consulting Fees: Amgen, AstraZeneca, Atherotech, Boehringer-Ingelheim, Kowa, Liposcience, Merck
Speakers Bureau: AbbVie, AstraZeneca, Genzyme, Kowa, Merck
Sergio Fazio, MD, PhD
Consulting Fees: Amarin, BASF, Kowa, Lupin, Merck, Roche, Sanofi
Allan D. Sniderman, MD
No relevant financial relationships to disclose.
Reviewers report the following relationship(s):
Michael Miller, MD
Consulting Fees: Amarin, AstraZeneca, GlaxoSmithKline
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.